Nantkwest Inc CS (NK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NK | VKTX | TLX | ||
| Company | Nantkwest Inc CS | Viking Thera | Telix Pharmaceuticals Limited ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 30.34 | 31.30 | 10.42 | ||
| High | 33.15 | 32.04 | 10.57 | ||
| Low | 29.74 | 31.02 | 10.40 | ||
| Latest | 32.49 | 31.70 | 10.52 | ||
| Change | +4.21 | +0.38 | +0.13 | ||
| % Change | +14.89% | +1.21% | +1.25% | ||
| Volume | 1,109,000 | 2,275,600 | 75,800 | ||
| 20-Day Average Volume | 1,620,320 | 2,358,480 | 152,565 | ||
| Previous Close | 28.28 | 31.32 | 10.39 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 31.51 | 32.54 | 10.67 | ||
| 20-Day Raw Stochastic | 41.94% | 38.25% | 37.10% | ||
| 20-Day Relative Strength | 58.89 | 46.50 | 55.54 | ||
| Weighted Alpha | +342.67 | +27.21 | -21.70 | ||
| Today's Opinion | 100% Buy | 56% Sell | 72% Buy | ||
| Previous Opinion | 80% Buy | 48% Sell | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 64% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.56% since 03/02/21 | -1.80% since 05/06/26 | -5.31% since 05/06/26 | ||
| Low | 23.15 on 03/05/21 | 30.82 on 05/12/26 | 10.26 on 05/12/26 | ||
| High | 33.15 on 03/09/21 | 32.67 on 05/11/26 | 11.05 on 05/07/26 | ||
| 1-Month | |||||
| %Chg | +15.79% since 02/09/21 | -9.45% since 04/13/26 | -6.41% since 04/13/26 | ||
| Low | 23.15 on 03/05/21 | 28.82 on 04/30/26 | 10.06 on 04/23/26 | ||
| High | 45.42 on 02/22/21 | 36.79 on 04/15/26 | 11.30 on 05/04/26 | ||
| 3-Month | |||||
| %Chg | +216.36% since 12/09/20 | +9.31% since 02/13/26 | +60.86% since 02/13/26 | ||
| Low | 10.00 on 12/10/20 | 28.80 on 02/17/26 | 6.28 on 02/17/26 | ||
| High | 45.42 on 02/22/21 | 37.50 on 03/13/26 | 11.48 on 04/13/26 | ||
| 6-Month | |||||
| %Chg | +393.77% since 09/09/20 | -18.72% since 11/13/25 | +10.62% since 11/13/25 | ||
| Low | 6.51 on 09/11/20 | 25.77 on 02/05/26 | 6.28 on 02/17/26 | ||
| High | 45.42 on 02/22/21 | 40.30 on 11/14/25 | 11.48 on 04/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,552,620 | 3,636,440 | 3,523,395 | ||
| Shares Outstanding, K | 109,345 | 116,106 | 339,114 | ||
| Annual Sales | 110,000 | 0 | 803,790,000 | ||
| Annual Net Income | -92,380,000 | -359,640,000 | -7,130,000 | ||
| Last Quarter Sales | 20,000 | 0 | N/A | ||
| Last Quarter Net Income | -32,140,000 | -158,330,000 | N/A | ||
| 60-Month Beta | 2.38 | 0.72 | 0.08 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.37 on 04/29/26 | N/A | ||
| Earnings Date | 03/24/21 | 07/22/26 | 05/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||